United Therapeutics Corporation
Martine A Rothblatt (Chairperson & CEO) sells UTHR shares
AI-generated summary
Chairperson & CEO, Director Martine A Rothblatt exercised 9,500 stock options at an average price of $117.76 for a value of $1,118,720, and sold 9,500 shares of Common Stock in open-market transactions at an average price of $539.99 for a value of $5,129,873.02. These transactions were made under a Rule 10b5-1 trading plan adopted on November 7, 2025. After the reported transactions, the insider holds 324,443 shares indirectly by Trust.
Key facts
- Insider
- Martine A Rothblatt · Chairperson & CEO, Director
Rule 10b5-1 plan · adopted Nov 7, 2025
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Oct 14, 2026 | M · exercise or conversion of a derivativeFootnotes F1, F2 | +9,500 | $117.76 | $1,118,720.00 | 333,943 | Indirect (by Trust) |
| Oct 14, 2026 | S · open-market saleFootnotes F1, F2 | −40 | $526.07 | $21,042.80 | 333,903 | Indirect (by Trust) |
| Oct 14, 2026 | S · open-market saleFootnotes F1, F3, F2 | −160 | $530.09 | $84,814.00 | 333,743 | Indirect (by Trust) |
| Oct 14, 2026 | S · open-market saleFootnotes F1, F4, F2 | −120 | $531.19 | $63,742.40 | 333,623 | Indirect (by Trust) |
| Oct 14, 2026 | S · open-market saleFootnotes F1, F2 | −40 | $532.48 | $21,299.20 | 333,583 | Indirect (by Trust) |
| Oct 14, 2026 | S · open-market saleFootnotes F1, F5, F2 | −240 | $534.63 | $128,311.99 | 333,343 | Indirect (by Trust) |
| Oct 14, 2026 | S · open-market saleFootnotes F1, F6, F2 | −400 | $535.89 | $214,356.12 | 332,943 | Indirect (by Trust) |
| Oct 14, 2026 | S · open-market saleFootnotes F1, F7, F2 | −633 | $537.19 | $340,038.61 | 332,310 | Indirect (by Trust) |
| Oct 14, 2026 | S · open-market saleFootnotes F1, F8, F2 | −1,127 | $538.00 | $606,326.34 | 331,183 | Indirect (by Trust) |
| Oct 14, 2026 | S · open-market saleFootnotes F1, F9, F2 | −525 | $539.09 | $283,023.14 | 330,658 | Indirect (by Trust) |
| Oct 14, 2026 | S · open-market saleFootnotes F1, F10, F2 | −2,002 | $540.23 | $1,081,544.26 | 328,656 | Indirect (by Trust) |
| Oct 14, 2026 | S · open-market saleFootnotes F1, F11, F2 | −1,930 | $541.20 | $1,044,509.05 | 326,726 | Indirect (by Trust) |
| Oct 14, 2026 | S · open-market saleFootnotes F1, F12, F2 | −883 | $542.07 | $478,644.37 | 325,843 | Indirect (by Trust) |
| Oct 14, 2026 | S · open-market saleFootnotes F1, F13, F2 | −400 | $543.15 | $217,261.80 | 325,443 | Indirect (by Trust) |
| Oct 14, 2026 | S · open-market saleFootnotes F1, F14, F2 | −480 | $544.35 | $261,288.91 | 324,963 | Indirect (by Trust) |
| Oct 14, 2026 | S · open-market saleFootnotes F1, F15, F2 | −480 | $545.48 | $261,830.02 | 324,483 | Indirect (by Trust) |
| Oct 14, 2026 | S · open-market saleFootnotes F1, F2 | −40 | $546.00 | $21,840.00 | 324,443 | Indirect (by Trust) |
| Oct 14, 2026 | M · exercise or conversion of a derivativeStock OptionFootnotes F1, F19, F20 | −9,500 | $0.00 | $0.00 | 233,410 | Indirect (by Trust) |
Footnotes
- F1 This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.
- F10 This transaction was executed in multiple trades at prices ranging from $539.64 to $540.63. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F11 This transaction was executed in multiple trades at prices ranging from $540.64 to $541.62. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F12 This transaction was executed in multiple trades at prices ranging from $541.66 to $542.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F13 This transaction was executed in multiple trades at prices ranging from $542.92 to $543.84. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F14 This transaction was executed in multiple trades at prices ranging from $543.95 to $544.92. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F15 This transaction was executed in multiple trades at prices ranging from $544.96 to $545.94. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F16 Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F17 Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F18 Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F19 These stock options vested in equal one-third installments on March 15, 2021, 2022 and 2023.
- F2 Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F20 Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries.
- F3 This transaction was executed in multiple trades at prices ranging from $529.75 to $530.72. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4 This transaction was executed in multiple trades at prices ranging from $530.76 to $531.70. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5 This transaction was executed in multiple trades at prices ranging from $534.14 to $535.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6 This transaction was executed in multiple trades at prices ranging from $535.43 to $536.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7 This transaction was executed in multiple trades at prices ranging from $536.62 to $537.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8 This transaction was executed in multiple trades at prices ranging from $537.64 to $538.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F9 This transaction was executed in multiple trades at prices ranging from $538.64 to $539.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
More UTHR filings
- 4
Filed Nov 9, 2026
- 144
Filed Nov 9, 2026
- 4
Filed Nov 6, 2026
- 4
Filed Nov 6, 2026
- 4
Filed Nov 5, 2026
- 4
Filed Nov 5, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.